Related Experiment Video
Updated: Apr 1, 2026
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity
Objective:
To study the mechanism of the inhibitory effect of ginsenoside Rg3 on colon cancer cell migration.
Methods:
Transwell migration assays were performed to investigate the inhibitory effect of ginsenoside Rg3 on SW480 cell migration. Electrophoretic mobility shift assays (EMSAs) and dual luciferase reporter assays were used to study the suppression capability of Rg3 on nuclear factor kappa B (NF-κB) activity. Western blotting was adopted to determine protein levels.
Results:
Two-hundred micromolar ginsenoside Rg3 significantly inhibited SW480 cell migration (P < 0.05). EMSA showed that Rg3 suppressed the DNA binding ability of NF-κB. Dual luciferase reporter assay showed that Rg3 decreased NF-κB-regulated gene transcription (P < 0.01). Western blots indicated that Rg3 down-regulated expression of the NF-κB-regulated matrix metalloproteinase 9, cyclooxygenase-2 and C-Myc. An NF-κB inhibitor, pyrrolidine dithiocarbamate, enhanced the inhibitory effect of Rg3 on SW480 cell migration.
Conclusion:
Ginsenoside Rg3 has a strong antitumor migration capability by suppressing NF-κB activity and expression of NF-κB-regulated gene products. It could be a good adjuvant for colon cancer patients during the course of chemotherapy.
Insights
Ginsenoside Rg3 effectively inhibits colon cancer cell migration by suppressing nuclear factor kappa B (NF-κB) activity. This natural compound shows potential as an adjuvant therapy for colon cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Colon cancer cell migration is a critical process in metastasis.
- Ginsenoside Rg3 is a natural compound with potential anticancer properties.
- Nuclear factor kappa B (NF-κB) signaling pathway is implicated in cancer progression.
Purpose of the Study:
- To elucidate the mechanism by which ginsenoside Rg3 inhibits colon cancer cell migration.
- To investigate the effect of ginsenoside Rg3 on NF-κB activity in colon cancer cells.
Main Methods:
- Transwell migration assays were used to assess cell migration.
- Electrophoretic mobility shift assays (EMSAs) and dual luciferase reporter assays were employed to evaluate NF-κB activity.
- Western blotting was utilized to determine protein expression levels.
Main Results:
- Ginsenoside Rg3 significantly inhibited SW480 colon cancer cell migration.
- Rg3 suppressed the DNA binding ability and transcriptional activity of NF-κB.
- Rg3 down-regulated the expression of NF-κB-regulated genes, including matrix metalloproteinase 9, cyclooxygenase-2, and C-Myc.
- An NF-κB inhibitor enhanced the inhibitory effect of Rg3 on cell migration.
Conclusions:
- Ginsenoside Rg3 exhibits potent antitumor migration capabilities by inhibiting NF-κB signaling.
- Rg3's mechanism involves suppressing NF-κB activity and downstream gene expression.
- Ginsenoside Rg3 may serve as a valuable adjuvant therapy for colon cancer.
